New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
November 8, 2012
07:27 EDTCBLICleveland BioLabs reports Q3 EPS (30c) vs (8c) in Q3 of 2011
Reports Q3 R&D expenses down to about $4.8M. Revenues for Q3 decreased to approximately $0.2M from approximately $3.8M in Q3 of 2011, primarily due to decreases in research sponsored by the DoD, BARDA and a NY State/RPCI Sponsored Research Agreement.
News For CBLI From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
March 2, 2015
07:44 EDTCBLICleveland BioLabs announces growth of Curaxin CBL0137 patent portfolio
Subscribe for More Information
February 27, 2015
18:02 EDTCBLICleveland BioLabs files to sell 2.07M shares of common stock for holders
Subscribe for More Information
February 24, 2015
07:39 EDTCBLICleveland BioLabs reports Q4 EPS ex-gain ($1.02) vs. (16c) last year
Subscribe for More Information
February 18, 2015
07:39 EDTCBLICleveland BioLabs announces receipt of letter from NASDAQ confirming compliance
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use